Chugai Pharmaceutical Co., Ltd. (TYO:4519)
Japan flag Japan · Delayed Price · Currency is JPY
8,349.00
-242.00 (-2.82%)
Apr 17, 2026, 3:30 PM JST

Chugai Pharmaceutical Ratios and Metrics

Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
14,138,75113,565,54411,516,9538,789,0535,540,4066,141,311
Market Cap Growth
24.15%17.79%31.04%58.64%-9.79%-32.11%
Enterprise Value
13,184,76512,683,09710,671,6358,170,2884,995,1115,744,662
Last Close Price
8591.008243.006763.315083.633150.633416.66
PE Ratio
32.5831.2629.7427.0014.8020.27
Forward PE
27.9229.0229.2626.5518.6122.33
PS Ratio
11.2410.789.847.914.406.14
PB Ratio
6.986.706.065.413.895.17
P/TBV Ratio
7.176.886.115.473.965.27
P/FCF Ratio
45.6143.7629.0026.0130.5328.74
P/OCF Ratio
36.6035.1225.7321.4422.7021.96
PEG Ratio
1.833.164.2023.024.082.37
EV/Sales Ratio
10.4810.089.127.353.975.75
EV/EBITDA Ratio
20.8820.0918.6017.358.8512.69
EV/EBIT Ratio
22.0221.1819.6918.609.3713.62
EV/FCF Ratio
42.5340.9126.8724.1727.5226.89
Debt / Equity Ratio
0.010.010.010.010.010.01
Debt / EBITDA Ratio
0.040.040.020.030.020.04
Debt / FCF Ratio
0.080.080.030.040.080.08
Net Debt / Equity Ratio
-0.47-0.47-0.52-0.45-0.34-0.38
Net Debt / EBITDA Ratio
-1.51-1.51-1.72-1.54-0.87-1.01
Net Debt / FCF Ratio
-3.08-3.08-2.48-2.15-2.69-2.13
Asset Turnover
0.540.540.560.590.740.72
Inventory Turnover
1.411.411.321.461.901.72
Quick Ratio
3.463.464.593.682.402.53
Current Ratio
4.244.245.534.743.153.25
Return on Equity (ROE)
22.10%22.10%21.96%21.34%28.67%27.95%
Return on Assets (ROA)
16.00%16.00%16.36%14.44%19.56%19.01%
Return on Invested Capital (ROIC)
41.30%43.74%42.57%35.09%45.09%45.33%
Return on Capital Employed (ROCE)
29.10%29.10%28.30%26.70%36.90%34.80%
Earnings Yield
3.07%3.20%3.36%3.70%6.76%4.93%
FCF Yield
2.19%2.28%3.45%3.84%3.28%3.48%
Dividend Yield
1.52%1.48%1.45%1.57%2.48%2.22%
Payout Ratio
68.99%68.99%34.40%40.43%36.91%32.56%
Buyback Yield / Dilution
-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%
Total Shareholder Return
1.52%1.47%1.44%1.56%2.47%2.21%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.